Literature DB >> 15733897

CA 125 half-life breakpoint between a "good" and "poor" prognosis in patients with ovarian cancer.

A Mano1, I Godinho, A C Falcão.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15733897     DOI： 10.1016/j.ijgo.2004.12.028

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  3 in total

Review 1.  CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review.

Authors:  G Colloca; A Venturino; I Governato
Journal:  Clin Transl Oncol       Date:  2015-11-06       Impact factor: 3.405

2.  Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer.

Authors:  R Sharma; J Graham; H Mitchell; A Brooks; S Blagden; H Gabra
Journal:  Br J Cancer       Date:  2009-02-17       Impact factor: 7.640

3.  The Effect of CA125 Nadir Level on Survival of Advanced-Stage Epithelial Ovarian Carcinoma after Interval Debulking Surgery.

Authors:  Jing Zeng; Huizhen Huang; Ying Shan; Yan Li; Ying Jin; Lingya Pan
Journal:  J Cancer       Date:  2017-09-20       Impact factor: 4.207
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.